Cooper Companies (NASDAQ: COO) — Research Brief

Context. The Cooper Companies, Inc. operates as a global medical device company through two business units: CooperVision (contact lenses) and CooperSurgical (fertility and women's health) [13], [15]. As of September 13, 2026, it carries an approximate market capitalization of ~$10.25B (point-in-time figure). The following is a synthesis of recent sources, not investment advice.

Recent Catalysts (last ~1–3 months)